Idexx Laboratories (IDXX) Non-Current Deferred Tax Liability (2016 - 2025)
Historic Non-Current Deferred Tax Liability for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $3.7 million.
- Idexx Laboratories' Non-Current Deferred Tax Liability fell 3418.17% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 3418.17%. This contributed to the annual value of $11.3 million for FY2024, which is 8984.01% down from last year.
- Per Idexx Laboratories' latest filing, its Non-Current Deferred Tax Liability stood at $3.7 million for Q3 2025, which was down 3418.17% from $2.1 million recorded in Q2 2025.
- Over the past 5 years, Idexx Laboratories' Non-Current Deferred Tax Liability peaked at $111.3 million during Q4 2023, and registered a low of $2.1 million during Q2 2025.
- In the last 5 years, Idexx Laboratories' Non-Current Deferred Tax Liability had a median value of $10.6 million in 2023 and averaged $24.7 million.
- Over the last 5 years, Idexx Laboratories' Non-Current Deferred Tax Liability had its largest YoY gain of 8001.08% in 2024, and its largest YoY loss of 8984.01% in 2024.
- Over the past 5 years, Idexx Laboratories' Non-Current Deferred Tax Liability (Quarter) stood at $106.7 million in 2021, then dropped by 8.77% to $97.3 million in 2022, then rose by 14.38% to $111.3 million in 2023, then plummeted by 89.84% to $11.3 million in 2024, then crashed by 67.08% to $3.7 million in 2025.
- Its last three reported values are $3.7 million in Q3 2025, $2.1 million for Q2 2025, and $8.1 million during Q1 2025.